Floatz logo

215 assets in Castration-Resistant Prostate Carcinoma

Therapeutic assets addressing Castration-Resistant Prostate Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Darolutamide
Castration-Resistant Prostate Carcinoma
BayerP4BBB (78)
Enzalutamide
Castration-Resistant Prostate Carcinoma
Prostate Cancer Clinical Trials ConsortiumP4BBB (73)
Prednisolone
Castration-Resistant Prostate Carcinoma
Ding-Wei YeP4BBB (72)
Cabozantinib
Castration-Resistant Prostate Carcinoma
Rana McKay, MDP3BB (70)
Mevrometostat
Castration-Resistant Prostate Carcinoma
Prostate Cancer Clinical Trials ConsortiumP3BB (70)
Radium Ra-223
Castration-Resistant Prostate Carcinoma
University of California, San FranciscoP4BB (70)
Abiraterone
Castration-Resistant Prostate Carcinoma
AstraZenecaP4BB (69)
Prednisone
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP4BB (69)
Atezolizumab
Castration-Resistant Prostate Carcinoma
Cancer Research UKP3BB (66)
Capivasertib
Castration-Resistant Prostate Carcinoma
Karolinska InstitutetP3BB (66)
Cyclophosphamide
Castration-Resistant Prostate Carcinoma
Zhejiang UniversityP2BB (66)
Goserelin
Castration-Resistant Prostate Carcinoma
BayerP3BB (66)
Immunoglobulin (H-Gamma1_L-Kappa)_Scfvkh-G1(H-Ch2-Ch3), Anti-[Homo Sapiens Klk2 (Kallikrein-2, Kallikrein Related Peptidase 2, Kallikrein 2 Prostatic) And Anti-[Homo Sapiens Cd3E (Cd3 Epsilon, Leu-4)], Homo Sapiens And Humanized Monoclonal Antibody, Bispecific, Bivalent
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP3BB (66)
Itraconazole
Castration-Resistant Prostate Carcinoma
PfizerP2BB (66)
Sipuleucel-T
Castration-Resistant Prostate Carcinoma
City of Hope Medical CenterP3BB (66)
Talazoparib
Castration-Resistant Prostate Carcinoma
Prostate Cancer Clinical Trials ConsortiumP2BB (65)
Docetaxel
Castration-Resistant Prostate Carcinoma
Charles Drew University of Medicine and ScienceP3BB (64)
Fulvestrant
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP2BB (64)
Lorigerlimab
Castration-Resistant Prostate Carcinoma
MacroGenicsP2BB (64)
Olaparib
Castration-Resistant Prostate Carcinoma
AstraZenecaP2/3BB (64)
Piflufolastat
Castration-Resistant Prostate Carcinoma
OHSU Knight Cancer InstituteP4BB (64)
Testosterone Cipionate
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer InstituteP2BB (64)
Vipivotide Tetraxetan
Castration-Resistant Prostate Carcinoma
Alliance for Clinical Trials in OncologyP3BB (64)
Carboplatin
Castration-Resistant Prostate Carcinoma
Alliance for Clinical Trials in OncologyP3B (63)
Leuporelin
Castration-Resistant Prostate Carcinoma
BayerP3B (63)
Nivolumab
Castration-Resistant Prostate Carcinoma
Rana McKay, MDP2B (63)
Apalutamide
Castration-Resistant Prostate Carcinoma
Mayo ClinicP3B (62)
Niraparib
Castration-Resistant Prostate Carcinoma
Latin American Cooperative Oncology GroupP3B (62)
Testosterone Enantate
Castration-Resistant Prostate Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2B (62)
Cabazitaxel
Castration-Resistant Prostate Carcinoma
Jina Pharmaceuticals Inc.P3B (61)
Carotuximab
Castration-Resistant Prostate Carcinoma
Edwin Posadas, MDP2B (61)
Pembrolizumab
Castration-Resistant Prostate Carcinoma
Cellbion Co., Ltd.P2B (61)
Testosterone Undecylate
Castration-Resistant Prostate Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2B (61)
Dexasone
Castration-Resistant Prostate Carcinoma
Acerand Therapeutics (Hong Kong) LimitedP3B (60)
Hrs-4357
Castration-Resistant Prostate Carcinoma
Jiangsu HengRui Medicine Co., Ltd.P3B (60)
Hydrocortisone
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP3B (60)
Letrozole
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP2B (60)
Omeprazole
Castration-Resistant Prostate Carcinoma
Wake Forest University Health SciencesP2B (60)
Regorafenib
Castration-Resistant Prostate Carcinoma
Translational Research in OncologyP2B (60)
Degarelix
Castration-Resistant Prostate Carcinoma
Mayo ClinicP3B (59)
Fludrocortisone
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP3B (59)
Ipilimumab
Castration-Resistant Prostate Carcinoma
ExelixisP2B (59)
Opevesostat
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP3B (59)
Cis-Diamminedichloroplatinum Ii
Castration-Resistant Prostate Carcinoma
Jonsson Comprehensive Cancer CenterP2B (58)
Pertuzumab
Castration-Resistant Prostate Carcinoma
Mayo ClinicP2B (58)
Relugolix
Castration-Resistant Prostate Carcinoma
Mayo ClinicP2B (58)
Trastuzumab
Castration-Resistant Prostate Carcinoma
Mayo ClinicP2B (58)
Cediranib
Castration-Resistant Prostate Carcinoma
National Cancer Institute (NCI)P2B (57)
Cetrelimab
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP2CCC (55)
Etoposide
Castration-Resistant Prostate Carcinoma
University of WashingtonP2CCC (55)
Showing 1 to 50 of 215 assets
PreviousPage 1 of 5Next